Neuroplasticity Market By Product Type
Neuroplasticity Market By Application
Neuroplasticity Market By End User
Neuroplasticity Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Neuroplasticity Market Snapshot
Chapter 4. Global Neuroplasticity Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product Type:
5.2.1. Software-Based Solutions
5.2.2. Hardware-Based Solutions
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
6.2.1. Stroke Rehabilitation
6.2.2. Traumatic Brain Injury (TBI) Rehabilitation
6.2.3. Neurodegenerative Disorders
6.2.4. Learning and Memory Enhancement
6.2.5. Mental Health Disorders
Chapter 7. Market Segmentation 3: By End-user Estimates & Trend Analysis
7.1. By End-user & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-user:
7.2.1. Hospitals and Clinics
7.2.2. Research Institutes and Academic Centers
7.2.3. Pharmaceutical and Biotechnology Companies
7.2.4. Others
Chapter 8. Neuroplasticity Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts By Product Type, 2021-2034
8.1.2. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.1.3. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts By End-user, 2021-2034
8.1.4. North America Neuroplasticity Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Neuroplasticity Market revenue (US$ Million) By Product Type, 2021-2034
8.2.2. Europe Neuroplasticity Market revenue (US$ Million) By Application, 2021-2034
8.2.3. Europe Neuroplasticity Market revenue (US$ Million) By End-user, 2021-2034
8.2.4. Europe Neuroplasticity Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Neuroplasticity Market revenue (US$ Million) By Product Type, 2021-2034
8.3.2. Asia Pacific Neuroplasticity Market revenue (US$ Million) By Application, 2021-2034
8.3.3. Asia Pacific Neuroplasticity Market revenue (US$ Million) By End-user, 2021-2034
8.3.4. Asia Pacific Neuroplasticity Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Neuroplasticity Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
8.4.2. Latin America Neuroplasticity Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.4.3. Latin America Neuroplasticity Market revenue (US$ Million) By End-user, (US$ Million) 2021-2034
8.4.4. Latin America Neuroplasticity Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Neuroplasticity Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
8.5.2. Middle East & Africa Neuroplasticity Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.5.3. Middle East & Africa Neuroplasticity Market revenue (US$ Million) By End-user, (US$ Million) 2021-2034
8.5.4. Middle East & Africa Neuroplasticity Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. NeuroSky Inc
9.2.2. Posit Science Corporation
9.2.3. BrainHQ
9.2.4. Synaptitude Brain Health
9.2.5. Mindmaze SA
9.2.6. NeuroVigil Inc
9.2.7. Lumosity
9.2.8. Neuronetics, Inc.
9.2.9. CogniFit, BrainHQ
9.2.10. Advanced Brain Monitoring
9.2.11. SharpBrains
9.2.12. Emotiv Inc
9.2.13. BrainCo
9.2.14. BrainHQ
9.2.15. Neuroscape
9.2.16. Neuroplast BV
9.2.17. Reha Technology AG
9.2.18. Virtualware Group
9.2.19. Nexeon Medsystems Inc.
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.